Literature DB >> 11837346

Stroke associated with alpha blocker therapy for benign prostatic hypertrophy.

George A Mansoor1, Beatriz E Tendler.   

Abstract

Benign enlargement of the prostate is a malady of older males, reaching an estimated prevalence of 90% in patients aged over 70 years. Many of these patients are treated with alpha blockers, which can lower blood pressure significantly. We report on a 64-year-old man who developed a right hemiparesis after taking one dose of doxazosin 4 mg for prostatic symptoms. A CT scan of the brain and carotid ultrasound studies were normal. He recovered most of his neurological function within a few days. Ambulatory blood pressure monitoring on doxazosin 2 mg revealed a striking sleep blood pressure reduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837346      PMCID: PMC2594088     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  14 in total

1.  Does extreme dipping of nocturnal blood pressure in elderly hypertensive patients confer high risk of developing ischemic target organ damage from antihypertensive therapy?

Authors:  K Kario; T G Pickering
Journal:  Arch Intern Med       Date:  2000-05-08

2.  Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.

Authors:  C C Schulman; T M Lock; J M Buzelin; F Boeminghaus; T P Stephenson; M Talja
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

3.  The clinical significance of diurnal blood pressure variations. Dippers and nondippers.

Authors:  T G Pickering
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

4.  Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects.

Authors:  G Manning; L Rushton; R Donnelly; M W Millar-Craig
Journal:  Am J Hypertens       Date:  2000-09       Impact factor: 2.689

5.  Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease.

Authors:  S D Pierdomenico; A Bucci; F Costantini; D Lapenna; F Cuccurullo; A Mezzetti
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

6.  Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky; W L Alward
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

7.  Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.

Authors:  J Y Gillenwater; R L Conn; S G Chrysant; J Roy; M Gaffney; K Ice; N Dias
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

8.  Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study.

Authors:  A Fawzy; K Braun; G P Lewis; M Gaffney; K Ice; N Dias
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

9.  Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction.

Authors:  D Sander; J Klingelhöfer
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

10.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

View more
  1 in total

1.  Risk of ischemic stroke during the initiation period of α-blocker therapy among older men.

Authors:  Chao-Lun Lai; Raymond Nien-Chen Kuo; Ho-Min Chen; Ming-Fong Chen; K Arnold Chan; Mei-Shu Lai
Journal:  CMAJ       Date:  2015-12-07       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.